SE421528B - Forfarande for framstellning av 8,8-disubstituerade 6-metylergoliner och derivat derav - Google Patents
Forfarande for framstellning av 8,8-disubstituerade 6-metylergoliner och derivat deravInfo
- Publication number
- SE421528B SE421528B SE7513753A SE7513753A SE421528B SE 421528 B SE421528 B SE 421528B SE 7513753 A SE7513753 A SE 7513753A SE 7513753 A SE7513753 A SE 7513753A SE 421528 B SE421528 B SE 421528B
- Authority
- SE
- Sweden
- Prior art keywords
- methylergolines
- disubstituted
- derivatives
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/530,320 US3968111A (en) | 1974-12-06 | 1974-12-06 | 8,8-Disubstituted-6-methylergolines and related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7513753L SE7513753L (sv) | 1976-06-08 |
| SE421528B true SE421528B (sv) | 1982-01-04 |
Family
ID=24113222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7513753A SE421528B (sv) | 1974-12-06 | 1975-12-05 | Forfarande for framstellning av 8,8-disubstituerade 6-metylergoliner och derivat derav |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US3968111A (xx) |
| JP (1) | JPS5813542B2 (xx) |
| AR (1) | AR211257A1 (xx) |
| AT (1) | AT348142B (xx) |
| AU (1) | AU505194B2 (xx) |
| BE (1) | BE836309A (xx) |
| BG (1) | BG33289A3 (xx) |
| CA (1) | CA1064918A (xx) |
| CH (1) | CH605937A5 (xx) |
| CS (1) | CS199610B2 (xx) |
| DD (1) | DD123750A5 (xx) |
| DE (1) | DE2554629A1 (xx) |
| DK (1) | DK146128C (xx) |
| ES (1) | ES443279A1 (xx) |
| FR (1) | FR2293204A1 (xx) |
| GB (1) | GB1535214A (xx) |
| GR (1) | GR59201B (xx) |
| HU (1) | HU173985B (xx) |
| IE (1) | IE42198B1 (xx) |
| IL (1) | IL48572A (xx) |
| NL (1) | NL7514177A (xx) |
| PH (1) | PH13133A (xx) |
| PL (1) | PL102611B1 (xx) |
| RO (1) | RO64606A (xx) |
| SE (1) | SE421528B (xx) |
| SU (1) | SU627757A3 (xx) |
| YU (1) | YU304575A (xx) |
| ZA (1) | ZA757510B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3968111A (en) * | 1974-12-06 | 1976-07-06 | Eli Lilly And Company | 8,8-Disubstituted-6-methylergolines and related compounds |
| USRE30219E (en) * | 1974-12-06 | 1980-02-19 | Eli Lilly And Company | Method of preparing 8,8-disubstituted-6-methylergolines and related compounds |
| US4054567A (en) * | 1975-08-11 | 1977-10-18 | Eli Lilly And Company | 6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds |
| US4098790A (en) * | 1976-09-15 | 1978-07-04 | Eli Lilly And Company | Ergoline chlorination process |
| US4238486A (en) * | 1979-11-23 | 1980-12-09 | Merck & Co., Inc. | Indolobenzoxazines |
| US4382940A (en) * | 1979-12-06 | 1983-05-10 | Farmitalia Carlo Erba S.P.A. | Ercoline derivatives and therapeutic compositions having CNS affecting activity |
| DE3001752A1 (de) * | 1980-01-16 | 1981-07-30 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen |
| CH644606A5 (de) * | 1980-09-23 | 1984-08-15 | Sandoz Ag | Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten. |
| US4801712A (en) * | 1985-06-24 | 1989-01-31 | Eli Lilly And Company | 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity |
| US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH344731A (de) * | 1956-05-18 | 1960-02-29 | Sandoz Ag | Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe |
| US2861074A (en) * | 1956-10-22 | 1958-11-18 | Lilly Co Eli | Substituted hydroxyergolenes |
| BE755211A (fr) * | 1969-08-29 | 1971-02-01 | Spofa Usines Pharma Reunies | Procede de preparation des nouvelles amides de l'acide d-6-methyl-8-ergolin/i/yle/acetique et de leurs sels, ainsi que les produits obtenus |
| AR206772A1 (es) * | 1972-07-21 | 1976-08-23 | Lilly Co Eli | Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina |
| US3968112A (en) * | 1974-08-02 | 1976-07-06 | Eli Lilly And Company | Synthesis of penniclavine and elymoclavine |
| US3968111A (en) * | 1974-12-06 | 1976-07-06 | Eli Lilly And Company | 8,8-Disubstituted-6-methylergolines and related compounds |
-
1974
- 1974-12-06 US US05/530,320 patent/US3968111A/en not_active Expired - Lifetime
-
1975
- 1975-11-20 CS CS757861A patent/CS199610B2/cs unknown
- 1975-11-28 GR GR49485A patent/GR59201B/el unknown
- 1975-11-28 ZA ZA757510A patent/ZA757510B/xx unknown
- 1975-11-29 RO RO7500084073A patent/RO64606A/ro unknown
- 1975-11-30 IL IL48572A patent/IL48572A/xx unknown
- 1975-12-01 CA CA240,828A patent/CA1064918A/en not_active Expired
- 1975-12-01 GB GB49208/75A patent/GB1535214A/en not_active Expired
- 1975-12-02 PH PH17826A patent/PH13133A/en unknown
- 1975-12-02 AU AU87181/75A patent/AU505194B2/en not_active Expired
- 1975-12-03 HU HU75EI656A patent/HU173985B/hu unknown
- 1975-12-03 AR AR261466A patent/AR211257A1/es active
- 1975-12-03 YU YU03045/75A patent/YU304575A/xx unknown
- 1975-12-03 JP JP50144580A patent/JPS5813542B2/ja not_active Expired
- 1975-12-04 DK DK547475A patent/DK146128C/da not_active IP Right Cessation
- 1975-12-04 NL NL7514177A patent/NL7514177A/xx not_active Application Discontinuation
- 1975-12-04 FR FR7537118A patent/FR2293204A1/fr active Granted
- 1975-12-04 SU SU752194708A patent/SU627757A3/ru active
- 1975-12-04 CH CH1580075A patent/CH605937A5/xx not_active IP Right Cessation
- 1975-12-04 PL PL1975185227A patent/PL102611B1/pl unknown
- 1975-12-04 IE IE2644/75A patent/IE42198B1/en unknown
- 1975-12-04 DE DE19752554629 patent/DE2554629A1/de not_active Withdrawn
- 1975-12-05 SE SE7513753A patent/SE421528B/xx unknown
- 1975-12-05 DD DD189911A patent/DD123750A5/xx unknown
- 1975-12-05 AT AT928075A patent/AT348142B/de not_active IP Right Cessation
- 1975-12-05 BE BE1007063A patent/BE836309A/xx not_active IP Right Cessation
- 1975-12-05 BG BG031707A patent/BG33289A3/xx unknown
- 1975-12-05 ES ES443279A patent/ES443279A1/es not_active Expired
-
1976
- 1976-01-19 US US05/650,582 patent/US4075212A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE432928B (sv) | Forfarande for framstellning 4,5,6-trinor-3,7-inter-m-fenylen-pge, och vissa derivat derav | |
| SE434946B (sv) | Forfarande for framstellning av acylsackariner och acyl-3-oxo-1,2-densisotiazoliner | |
| SE423996B (sv) | Forfarande for framstellning av daunomycin- och adriamycin-derivat | |
| SE7604475L (sv) | Forfarande for framstellning av 1,1,1-triaryl-alkylaminer | |
| SE421319B (sv) | Forfarande for framstellning av etbara polysackarider och polysackaridderivat | |
| SE409452B (sv) | Forfarande for framstellning av stilbenderivat | |
| SE421528B (sv) | Forfarande for framstellning av 8,8-disubstituerade 6-metylergoliner och derivat derav | |
| SE7506237L (sv) | Forfarande for framstellning av dekahydroisokinolinderivat | |
| SE7513606L (sv) | Derivat av tetanustoxineta forfarande for deras framstellning och medel innehallande desamma | |
| SE7613839L (sv) | Forfarande for framstellning av 2(1h)-kinazolinonderivat | |
| SE421315B (sv) | Forfarande for framstellning av vinkamin och derivat derav | |
| SE428015B (sv) | Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat | |
| SE7507648L (sv) | Forfarande for framstellning av basiskt substituerade derivat av 4-hydroxi-bensimidazol | |
| SE7513739L (sv) | Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat | |
| SE428922B (sv) | Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner | |
| SE7506196L (sv) | Forfarande for framstellning av amidin-hydrazon-derivat | |
| SE388854B (sv) | Forfarande for framstellning av fenylpyridylaminderivat | |
| SE415659B (sv) | Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat | |
| SE420999B (sv) | Framstellning av 2,4-diamino-5-bensylpyrimidiner | |
| SE400086B (sv) | Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat | |
| SE423814B (sv) | Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat | |
| SE404186B (sv) | Forfarande for framstellning av cyklopropanolderivat | |
| SE7605518L (sv) | Forfarande for framstellning av 3,5-bisoxygenerade 2-(omega-halogen-3-oxygenerad-l-alkenyl)cyklopentan-l-heptansyror och derivat derav | |
| SE7709402L (sv) | Forfarande for framstellning av tetrahydropyridinderivat | |
| SE414404B (sv) | Forfarande for framstellning av 2(1h)-kinazolinonderivat |